Literature DB >> 9780970

Prostate cancer: 2. Natural history.

R K Nam1, M A Jewett, M D Krahn.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9780970      PMCID： PMC1229700     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  42 in total

1.  Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.

Authors:  T A Stamey; N Yang; A R Hay; J E McNeal; F S Freiha; E Redwine
Journal:  N Engl J Med       Date:  1987-10-08       Impact factor: 91.245

2.  Incidental adenocarcinoma after open prostatic adenectomy.

Authors:  T J Stillwell; R S Malek; D E Engen; G M Farrow
Journal:  J Urol       Date:  1989-01       Impact factor: 7.450

3.  Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging.

Authors:  D F Gleason; G T Mellinger
Journal:  J Urol       Date:  1974-01       Impact factor: 7.450

4.  Deferred treatment for prostate cancer.

Authors:  R Handley; T W Carr; D Travis; P H Powell; R R Hall
Journal:  Br J Urol       Date:  1988-09

5.  A convenient approximation of life expectancy (the "DEALE"). II. Use in medical decision-making.

Authors:  J R Beck; S G Pauker; J E Gottlieb; K Klein; J P Kassirer
Journal:  Am J Med       Date:  1982-12       Impact factor: 4.965

6.  The course and prognosis of different forms of chronic airways obstruction in a sample from the general population.

Authors:  B Burrows; J W Bloom; G A Traver; M G Cline
Journal:  N Engl J Med       Date:  1987-11-19       Impact factor: 91.245

7.  Cancer of the prostate: is there a need for aggressive treatment?

Authors:  B Moskovitz; S Nitecki; D Richter Levin
Journal:  Urol Int       Date:  1987       Impact factor: 2.089

8.  A convenient approximation of life expectancy (the "DEALE"). I. Validation of the method.

Authors:  J R Beck; J P Kassirer; S G Pauker
Journal:  Am J Med       Date:  1982-12       Impact factor: 4.965

9.  Natural history of localised prostatic cancer managed by conservative therapy alone.

Authors:  N J George
Journal:  Lancet       Date:  1988-03-05       Impact factor: 79.321

10.  Pathological factors that influence prognosis in stage A prostatic cancer: the influence of extent versus grade.

Authors:  B B Cantrell; D P DeKlerk; J C Eggleston; J K Boitnott; P C Walsh
Journal:  J Urol       Date:  1981-04       Impact factor: 7.450
View more
  8 in total

1.  Prostate cancer from a patient's perspective.

Authors:  D Grundy
Journal:  CMAJ       Date:  1999-06-29       Impact factor: 8.262

2.  Understanding obesity.

Authors:  J D Douketis
Journal:  CMAJ       Date:  1999-06-29       Impact factor: 8.262

3.  The more the better?

Authors:  M Simunovic; T To; B Langer
Journal:  CMAJ       Date:  1999-06-29       Impact factor: 8.262

4.  Understanding obesity.

Authors:  T M Stein
Journal:  CMAJ       Date:  1999-06-29       Impact factor: 8.262

5.  PSA screening: a view from the front lines. North York General-Branson Practice-Based Small Group.

Authors:  M Greiver; N Rosen
Journal:  CMAJ       Date:  2000-03-21       Impact factor: 8.262

6.  Radical prostatectomy as treatment for prostate cancer.

Authors:  Michael A S Jewett; Neil Fleshner; Lawrence H Klotz; Robert K Nam; John Trachtenberg
Journal:  CMAJ       Date:  2003-01-07       Impact factor: 8.262

Review 7.  Prostate cancer: 6. Surgical treatment of localized disease.

Authors:  S L Goldenberg; E W Ramsey; M A Jewett
Journal:  CMAJ       Date:  1998-11-17       Impact factor: 8.262

Review 8.  The role of bisphosphonates in the management of prostate cancer.

Authors:  Fred Saad
Journal:  Curr Oncol Rep       Date:  2006-05       Impact factor: 5.075
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.